Polycystic Ovary Syndrome: the Epigenetics Behind the Disease

Autor(es)

Eiras, Matheus Credendio ; Pinheiro, Daniel Pascoalino ; Romcy, Kalil Andrade Mubarac ; Ferriani, Rui Alberto ; Dos Reis, Rosana Maria ; Furtado, Cristiana Libardi Miranda

• Tipo de documento: Artigo Científico
• Fonte: REPRODUCTIVE SCIENCES; v. 29, n. 3, p. 15-pg., 2021-04-07.

Resumo

Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders, affecting approximately 5-20% of women of reproductive age. PCOS is a multifactorial, complex, and heterogeneous disease, characterized by hyperandrogenism, ovulatory dysfunction, and polycystic ovaries, which may lead to impaired fertility. Besides the reproductive outcomes, multiple comorbidities, such as metabolic disturbances, insulin resistance, obesity, diabetes, and cardiovascular disease, are associated with PCOS. In addition to the clear genetic basis, epigenetic alterations may also play a central role in PCOS outcomes, as environmental and hormonal alterations directly affect clinical manifestations and PCOS development. Here, we highlighted the epigenetic modifications in the multiplicity of clinical manifestations, as well as environmental epigenetic disruptors, as intrauterine hormonal and metabolic alterations affecting embryo development and the adulthood lifestyle, which may contribute to PCOS development. Additionally, we also discussed the new approaches for future studies and potential epigenetic biomarkers for the treatment of associated comorbidities and improvement in quality of life of women with PCOS. (AU)

• Processo FAPESP: 12/11069-9 - Polimorfismo cag do receptor de andrógenos e comprimento do telômero em pacientes com falência ovariana prematura
• Beneficiário: Cristiana Libardi Miranda Furtado
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado
• Processo FAPESP: 15/14031-0 - Efeitos do treinamento físico aeróbio nos parametros moleculares, metabólicos, hormonais e composição corporal em mulheres com a síndrome dos ovários policísticos: um ensaio clínico controlado
• Beneficiário: Rosana Maria dos Reis
• Modalidade de apoio: Auxílio à Pesquisa - Regular